Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Armstrong AJ, Azad AA, Iguchi T, Szmulewitz RZ, et al. J Clin Oncol 2022 Apr 14:JCO2200193. doi: 10.1200/JCO.22.00193.

Read + Share

Amedeo Smart

Independent Medical Education

Armstrong AJ, Azad AA, Iguchi T, Szmulewitz RZ, et al. Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol 2022 Apr 14:JCO2200193. doi: 10.1200/JCO.22.00193.
PMID: 35420921